Literature DB >> 12720123

Origins of the malignant clone in typical Waldenstrom's macroglobulinemia.

Surinder S Sahota1, Francesco Forconi, Christian H Ottensmeier, Freda K Stevenson.   

Abstract

Histopathology and phenotypic considerations in IgM-secreting B-cell tumors allow distinction between different diseases, but insight into pathogenesis is restricted. Here, variable region (V) gene analysis can complement classification but, more importantly, can also reveal disease origins and clonal history. We used V(H) gene analysis to probe origins in Waldenstrom's macroglobulinemia (WM), and contrasted these with the less malignant counterpart, IgM-secreting monoclonal gammopathy of undetermined significance (MGUS). Limited data on WM sequences had previously shown evidence for somatic mutation, but with conflicting analysis of intraclonal variation in tumor sequences. To further the investigation, we analyzed seven cases of WM and compared these with three cases of IgM MGUS. In both diseases, V(H) genes were somatically mutated with no evidence of intraclonal variation, even at the MGUS stage. A sensitive V(H) gene-probe assay revealed no evidence for isotype switch transcripts in any of the WM and IgM MGUS cases. These findings reveal an origin of WM and IgM MGUS from a IgM cell, which transforms after cessation of somatic mutation but without initiating switch events. In contrast, IgM-secreting multiple myeloma arises at a later stage in differentiation, when isotype switch mechanisms have been engaged. Copyright 2003 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12720123     DOI: 10.1053/sonc.2003.50072

Source DB:  PubMed          Journal:  Semin Oncol        ISSN: 0093-7754            Impact factor:   4.929


  5 in total

Review 1.  Molecular pathogenesis of Waldenstrom's macroglobulinemia.

Authors:  Esteban Braggio; Casey Philipsborn; Anne Novak; Lucy Hodge; Stephen Ansell; Rafael Fonseca
Journal:  Haematologica       Date:  2012-07-06       Impact factor: 9.941

2.  Aberrant Extrafollicular B Cells, Immune Dysfunction, Myeloid Inflammation, and MyD88-Mutant Progenitors Precede Waldenstrom Macroglobulinemia.

Authors:  Kavita M Dhodapkar; Madhav V Dhodapkar; Akhilesh Kaushal; Ajay K Nooka; Allison R Carr; Katherine E Pendleton; Benjamin G Barwick; Julia Manalo; Samuel S McCachren; Vikas A Gupta; Nisha S Joseph; Craig C Hofmeister; Jonathan L Kaufman; Leonard T Heffner; Stephen M Ansell; Lawrence H Boise; Sagar Lonial
Journal:  Blood Cancer Discov       Date:  2021-09-01

3.  TCL1 expression patterns in Waldenström macroglobulinemia.

Authors:  Richard Lemal; Sandrine Bard-Sorel; Laura Montrieul; Jacques-Olivier Bay; Aurélie Ravinet; Albane Ledoux-Pilon; Nicolas Cagnard; Sébastien Bailly; Pierre Morel; Frédéric Charlotte; Xavier Leleu; Stéphanie Poulain; Pierre J Déchelotte; Olivier Hermine; Véronique Leblond; Olivier Tournilhac; Romain Guièze
Journal:  Mod Pathol       Date:  2015-10-23       Impact factor: 7.842

4.  B-Cell-Specific Myd88 L252P Expression Causes a Premalignant Gammopathy Resembling IgM MGUS.

Authors:  Kristin Schmidt; Ulrike Sack; Robin Graf; Wiebke Winkler; Oliver Popp; Philipp Mertins; Thomas Sommermann; Christine Kocks; Klaus Rajewsky
Journal:  Front Immunol       Date:  2020-12-01       Impact factor: 7.561

Review 5.  Waldenström macroglobulinemia: clinical and immunological aspects, natural history, cell of origin, and emerging mouse models.

Authors:  Siegfried Janz
Journal:  ISRN Hematol       Date:  2013-09-09
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.